- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04974489
Correcting Public Misperceptions About Very Low Nicotine Content Cigarettes
Study Overview
Status
Conditions
Detailed Description
In this study we will assess whether messages about the harm of VLNC cigarettes reduce the misperception that they are less harmful than regular cigarettes.
Recruitment:
We will enroll participants from an existing nationally representative panel.
Informed Consent:
Potential participants are part of an existing nationally representative panel and have already consented to participate in the panel. Before enrolling, participants will also be asked to consent to participate in this study via a consent form included in the study survey.
Randomization:
Survey software will randomly allocate participants to one of the four arms of the study (3 intervention arms or a control arm). Each study arm will have approximately the same number of participants.
Assessment:
Participants will complete a 15-minute survey. The survey will begin with an introduction to the concept of VLNC cigarettes. Then participants will be shown intervention or control messages, and their beliefs will be assessed.
Detailed Description of the Intervention:
Participants will be shown a set of 3 messages about the harms of VLNC cigarettes (intervention arms) or about littering (control arm). Each of the 3 intervention arms use a different theme to attempt to correct the VLNC misperception.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27514
- University of North Carolina, Chapel Hill
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Current Cigarette Smoker
- Age 18 or older
- Enrolled in existing nationally representative panel where recruitment is based
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Emotion-based messages about the harm of VLNC
|
Participants in this arm will receive 3 emotion-based messages about the harm of VLNC during the survey data collection.
|
Experimental: Continued-harm-framed messages about the harm of VLNC
|
Participants in this arm will receive 3 continued-harm-framed messages about the harm of VLNC during the survey data collection.
|
Experimental: Myth-refuting messages about the harm of VLNC
|
Participants in this arm will receive 3 myth-refuting messages messages about the harm of VLNC during the survey data collection.
|
Active Comparator: Control messages about littering
|
Participants in this arm will receive 3 control messages about littering during the survey data collection.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Very Low Nicotine Content (VLNC) Misperception
Time Frame: During one day survey
|
Measured by a 3 item scale.
Very low nicotine content (VLNC) Misperception measured with 3 questions, the final VLNC misperception score is a mean of the response to the 3 questions, on a scale of 1 to 5, where 1 indicates a perception that VLNC are much more harmful than other cigarettes, and 5 indicates a perception that VLNC are much less harmful than other cigarettes, and 3 is a perception that VLNC are as harmful as other cigarettes.
|
During one day survey
|
Percentage of Participants With Very Low Nicotine Content (VLNC) Misperception About Harm (Dichotomized)
Time Frame: During one day survey
|
Very low nicotine content (VLNC) Misperception of Harm was measured with 1 question, on a scale of 1 to 5, where 1 indicates a perception that VLNC are much more harmful than other cigarettes, and 5 indicates a perception that VLNC are much less harmful than other cigarettes, and 3 is a perception that VLNC are as harmful as other cigarettes.
The results were dichotomized to indicate the percentage of people who hold the misperception.
Specifically, responses of "much less likely" (5) or "less likely" (4) were recoded as 1 (having the misperception), and responses of "Much more likely" (1), "More likely" (2), or "As likely" (3) were recoded as 0 (not having the misperception).
|
During one day survey
|
Percentage of Participants With Very Low Nicotine Content (VLNC) Misperception About Cancer (Dichotomized)
Time Frame: During one day survey
|
Very low nicotine content (VLNC) Misperception of Risk of Cancer was measured with 1 question, on a scale of 1 to 5, where 1 indicates a perception that VLNC are much more likely to cause cancer than other cigarettes, and 5 indicates a perception that VLNC are much less likely to cause cancer than other cigarettes, and 3 is a perception that VLNC are as likely to cause cancer as other cigarettes.
The results were dichotomized to indicate the percentage of people who hold the misperception.
Specifically, responses of "much less likely" (5) or "less likely" (4) were recoded as 1 (having the misperception), and responses of "Much more likely" (1), "More likely" (2), or "As likely" (3) were recoded as 0 (not having the misperception).
|
During one day survey
|
Percentage of Participants With Very Low Nicotine Content (VLNC) Misperception About Death (Dichotomized)
Time Frame: During one day survey
|
Very low nicotine content (VLNC) Misperception of Risk of Death was measured with 1 question, on a scale of 1 to 5, where 1 indicates a perception that VLNC are much more likely to cause death than other cigarettes, and 5 indicates a perception that VLNC are much less likely to cause death than other cigarettes, and 3 is a perception that VLNC are as likely to cause death as other cigarettes.
The results were dichotomized to indicate the percentage of people who hold the misperception.
Specifically, responses of "much less likely" (5) or "less likely" (4) were recoded as 1 (having the misperception), and responses of "Much more likely" (1), "More likely" (2), or "As likely" (3) were recoded as 0 (not having the misperception).
|
During one day survey
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quit Intentions
Time Frame: During one day survey
|
Measured by a 3 item scale.
Quit intention measured with 3 questions, the final quit intention score is a mean of the response to the 3 questions, on a scale of 1 to 5, where 1 indicates low intention to quit smoking, and 5 indicates a high intention to quit.
|
During one day survey
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perceived Message Effectiveness
Time Frame: During one day survey
|
Measured by a 3 item scale after each message, 9 items total.
Perceived message effectiveness measured with 3 questions per message.
The final perceived message effectiveness score is a mean of the response to the 3 questions, on a scale of 1 to 5, where 1 indicates low perceived message effectiveness, and 5 indicates high perceived message effectiveness.
|
During one day survey
|
Perceived Understandability
Time Frame: During one day survey
|
Perceived Understandability is measured with 1 question on a scale of 1 to 5: "How easy was it to understand the three black and white messages we showed you earlier?", where 1 = "Not at all", 5 = "Very", and 3 = "Somewhat"
|
During one day survey
|
Attention
Time Frame: During one day survey
|
Attention is measured with 1 question on a scale of 1 to 5: "How much did the messages grab your attention?",
where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"
|
During one day survey
|
Negative Affect
Time Frame: During one day survey
|
Negative affect is measured with 1 question on a scale of 1 to 5: "How much did the messages make you feel scared?",
where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"
|
During one day survey
|
Cognitive Reactions
Time Frame: During one day survey
|
Cognitive Reactions are measured with 1 question on a scale of 1 to 5: "How much did the messages make you think about the risk of smoking cigarettes that have 95% less nicotine?",
where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"
|
During one day survey
|
Social Interactions
Time Frame: During one day survey
|
Social Interactions are measured with 1 question on a scale of 1 to 5: "How much would you talk with other people about the messages?",
where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"
|
During one day survey
|
Reactance
Time Frame: During one day survey
|
Reactance is measured with 1 question on a scale of 1 to 5: "How much do you feel that the messages are trying to manipulate you?", where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"
|
During one day survey
|
Interest in Other Nicotine Products
Time Frame: During one day survey
|
Measured by a 3 item scale.
Interest in other nicotine products with 3 questions, the final score is a mean of the response to the 3 questions, on a scale of 1 to 5, where 1 indicates low interest in other nicotine products, and 5 indicates a high interest in other nicotine products.
|
During one day survey
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: M. Justin Byron, PhD, University of North Carolina, Chapel Hill
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 19-1284
- R21CA234968 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Use, Cigarette Use
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
University of VirginiaVirginia Foundation for Healthy YouthRecruitingTobacco Use | Electronic Cigarette Use | Tobacco Use CessationUnited States
-
Mikhail N KoffarnusNational Institute on Drug Abuse (NIDA)Not yet recruitingTobacco Use | Cigarette Use
-
University of PennsylvaniaNational Cancer Institute (NCI)Not yet recruitingTobacco Use | Harm Reduction | Cigarette Smoking | E-cigarette Use
-
Lund UniversityRecruitingSmoking | Tobacco Use | Cigarette Use, ElectronicSweden
-
RAI Services CompanyRecruitingSmoking | Tobacco Use | Electronic Cigarette UseUnited States
-
University of Wisconsin, MilwaukeeRecruitingTobacco Use Cessation | E-cigarette UseUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
Clinical Trials on Emotion-based messages about the harm of VLNC
-
Centers for Disease Control and PreventionColorado Department of Public Health and Environment; San Francisco Department... and other collaboratorsCompletedSexually Transmitted Diseases | HIV
-
The University of Hong KongRecruiting
-
The University of Hong KongRecruiting
-
University of Ljubljana, Faculty of MedicineUniversity Medical Centre Ljubljana; University Maribor; University Psychiatric...RecruitingNon-Suicidal Self Injury | Self-harm | Personality Disorder, Borderline | Difference, Individual | Epigenetic Disorder | Change; MentalSlovenia